Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies, such as anti-thymocyte globulin, may stimulate the immune
system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, such
as melphalan, work in different ways to stop the growth of cancer cells, either by killing
the cells or by stopping them from dividing. Anti-thymocyte globulin may also make cancer
cells more sensitive to melphalan. Giving anti-thymocyte globulin together with melphalan may
kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving anti-thymocyte globulin together
with melphalan works in treating patients with relapsed multiple myeloma.